Cardiovascular Diseases

Night Shift Work Linked to Higher Cardiovascular–Kidney–Metabolic Risk, Especially With Short Sleep

Long-term and intensive night shift work was associated with a significantly higher risk of cardiovascular–kidney–metabolic (CKM) disease in a large UK Biobank cohort, with the strongest effects seen among individuals who slept six hours or less per night. Among 96,365 participants followed through 2022, those with more than 20 years of night shift work, 8+ nightshifts monthly, or over 1200 lifetime nightshifts had 32–36% higher CKM risk compared with day workers, independent of demographic and socioeconomic factors. A clear dose–response relationship was observed across measures of night work exposure, and sleep duration significantly modified this association, amplifying risk in short sleepers (≤6 hours), whereas chronotype did not. These findings suggest that prolonged night shift work contributes to CKM disease burden and adequate sleep duration may be a potential mitigating factor for workers exposed to circadian disruption. Source: https://academic.oup.com/eurjpc/

hyangiu

Recent Posts

Early-Life Sugar Restriction Linked to Lower Risk of Early-Onset Cancer

Early-life sugar restriction during pregnancy and infancy was associated with a 34% lower risk of…

2 days ago

Domain-Specific Physical Activity and Dementia Risk

Higher levels of physical activity were associated with lower risks of all-cause dementia, Alzheimer’s disease,…

5 days ago

BMI and Waist Circumference Jointly Predict Mortality Risk in Older Adults

In US adults aged ≥65 years, overweight and class I–II obesity were associated with lower…

5 days ago

Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined…

6 days ago

The Obesity Paradox in Colorectal Cancer May Reflect Prediagnostic Weight Loss

In the German multicenter study of 5,521 patients with colorectal cancer (CRC), the apparent survival…

1 week ago

Stopping Statins for Primary Prevention After Age 75? Evidence from a Randomized Trial

In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD)…

2 weeks ago

This website uses cookies.